BMY vs. PGR
BMY (Bristol-Myers Squibb Company) and PGR (The Progressive Corporation) are both stocks. BMY operates in Drug Manufacturers - General (Healthcare), while PGR operates in Insurance - Property & Casualty (Financial Services). Over the past 10 years, BMY returned 0.92%/yr vs 23.53%/yr for PGR. At a 0.25 correlation, their price movements are largely independent.
Performance
BMY vs. PGR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BMY achieves a 8.54% return, which is significantly higher than PGR's -4.67% return. Over the past 10 years, BMY has underperformed PGR with an annualized return of 0.92%, while PGR has yielded a comparatively higher 23.53% annualized return.
BMY
- 1D
- 1.18%
- 1M
- 1.20%
- YTD
- 8.54%
- 6M
- 12.26%
- 1Y
- 25.69%
- 3Y*
- 0.16%
- 5Y*
- 1.52%
- 10Y*
- 0.92%
PGR
- 1D
- 4.42%
- 1M
- 3.67%
- YTD
- -4.67%
- 6M
- -2.60%
- 1Y
- -22.46%
- 3Y*
- 19.82%
- 5Y*
- 17.85%
- 10Y*
- 23.53%
BMY vs. PGR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 8.54% | 0.11% | 15.81% | -26.14% | 18.98% | 2.88% | 0.41% | 27.74% | -12.90% | 7.71% |
PGR The Progressive Corporation | -4.67% | -3.02% | 51.39% | 23.16% | 26.81% | 10.84% | 41.48% | 25.14% | 9.39% | 61.59% |
Correlation
The correlation between BMY and PGR is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Jul 10, 1986 | 0.25 |
The correlation between BMY and PGR shifts across timeframes, from 0.05 (1 year) to 0.25 (all time), reflecting how their relationship changes across market environments.
Fundamentals
BMY:
$3.57
PGR:
$19.23
BMY:
16.06
PGR:
10.61
BMY:
0.92
PGR:
0.08
BMY:
2.41
PGR:
1.37
BMY:
$48.48B
PGR:
$87.65B
BMY:
$33.33B
PGR:
$23.23B
BMY:
$13.34B
PGR:
$14.81B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BMY vs. PGR — Risk / Return Rank
BMY
PGR
BMY vs. PGR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bristol-Myers Squibb Company (BMY) and The Progressive Corporation (PGR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BMY | PGR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.96 | ||
| Sortino ratioReturn per unit of downside risk | +2.89 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 0.85 | +0.34 |
| Calmar ratioReturn relative to maximum drawdown | 1.89 | -0.82 | +2.71 |
| Martin ratioReturn relative to average drawdown | 4.15 | -1.20 | +5.35 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BMY | PGR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.96 | -1.00 | +1.96 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.06 | 0.73 | -0.67 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.04 | 0.96 | -0.93 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.35 | 0.58 | -0.23 |
Drawdowns
BMY vs. PGR - Drawdown Comparison
The maximum BMY drawdown since its inception was -72.03%, roughly equal to the maximum PGR drawdown of -71.06%. Use the drawdown chart below to compare losses from any high point for BMY and PGR.
Loading charts...
Drawdown Indicators
| BMY | PGR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -72.03% | -71.06% | -0.97% |
Max Drawdown (1Y)Largest decline over 1 year | -13.68% | -27.41% | +13.73% |
Max Drawdown (3Y)Largest decline over 3 years | -36.85% | -30.35% | -6.50% |
Max Drawdown (5Y)Largest decline over 5 years | -47.67% | -30.35% | -17.32% |
Max Drawdown (10Y)Largest decline over 10 years | -47.67% | -30.35% | -17.32% |
Current DrawdownCurrent decline from peak | -17.59% | -25.37% | +7.78% |
Average DrawdownAverage peak-to-trough decline | -22.38% | -14.53% | -7.85% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.21% | 18.97% | -12.76% |
Volatility
BMY vs. PGR - Volatility Comparison
Bristol-Myers Squibb Company (BMY) and The Progressive Corporation (PGR) have volatilities of 7.08% and 7.32%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BMY | PGR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.08% | 7.32% | -0.24% |
Volatility (6M)Calculated over the trailing 6-month period | 17.90% | 16.85% | +1.05% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.83% | 22.65% | +4.18% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.02% | 24.59% | -0.57% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.25% | 24.47% | +0.78% |
Dividends
BMY vs. PGR - Dividend Comparison
BMY's dividend yield for the trailing twelve months is around 4.37%, less than PGR's 6.81% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 4.37% | 4.60% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% |
PGR The Progressive Corporation | 6.81% | 2.15% | 0.48% | 0.25% | 0.31% | 6.23% | 2.68% | 3.89% | 1.86% | 1.21% | 2.50% | 2.16% |
Financials
BMY vs. PGR - Financials Comparison
This section allows you to compare key financial metrics between Bristol-Myers Squibb Company and The Progressive Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BMY vs. PGR - Profitability Comparison
BMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a gross profit of 8.07B and revenue of 11.49B. Therefore, the gross margin over that period was 70.2%.
PGR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, The Progressive Corporation reported a gross profit of 6.66B and revenue of 22.74B. Therefore, the gross margin over that period was 29.3%.
BMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported an operating income of 3.27B and revenue of 11.49B, resulting in an operating margin of 28.5%.
PGR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, The Progressive Corporation reported an operating income of 3.68B and revenue of 22.74B, resulting in an operating margin of 16.2%.
BMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a net income of 2.68B and revenue of 11.49B, resulting in a net margin of 23.3%.
PGR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, The Progressive Corporation reported a net income of 2.95B and revenue of 22.74B, resulting in a net margin of 13.0%.
Frequently Asked Questions
BMY and PGR have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PGR has higher volatility (7.32%) compared to BMY (7.08%). In terms of maximum drawdown, BMY dropped -72.03% vs PGR's -71.06%.
BMY currently has the higher Sharpe Ratio (0.96 vs -1.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BMY and PGR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer